ClinicalTrials.govpublic full text
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
neoplasms, urothelial carcinomas, non-squamous non-small cell lung carcinomas, refractory gastrointestinal carcinomas, hsp90 inhibitor, sarcomas, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893430
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.